This handout is for cardiac tamponade — chylopericardium (chylous pericardial effusion). Your care team identified this based on: pericardial effusion with milky/opalescent fluid on pericardiocentesis aspirate — chylopericardium until proven otherwise (akamatsu ann thorac surg 1994 pmid 8311605; esc 2015 §specific etiologies).
Other reasons your team may use this plan: pericardial fluid triglycerides >500 mg/dl with chylomicrons on lipoprotein electrophoresis (pericardial > serum tg ratio >1) (akamatsu pmid 8311605; imazio jama 2015 pmid 26461998); post-cardiothoracic surgery (cabg, transplant, congenital repair) with new pericardial effusion within 30 days — high suspicion for thoracic-duct injury chylopericardium (kshettry ann thorac surg 1996; riquet ejcts 1996); mediastinal mass on ct/mri with pericardial effusion → lymphoma-related chylopericardium concern (imazio jacc 2020 pmid 32919577; lyon ehj 2022 pmid 35993161).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| medium_chain_triglyceride_diet | MCT-based formula or oil 1-2 g/kg/day; total dietary fat <5 g/day; supplement fat-soluble vitamins (A, D, E, K) | enteral | continuous nutritional intervention × 4-6 wk | Akamatsu Ann Thorac Surg 1994 PMID 8311605 — MCTs absorbed directly into portal vein bypassing thoracic duct; reduces chyle production; ~50-70% resolve with diet alone in 4-6 wk |
| total_parenteral_nutrition_TPN | fat-free or MCT-only TPN per nutrition team | IV | continuous TPN | Bowel rest with TPN further reduces chyle production; for refractory cases or malnutrition (Akamatsu PMID 8311605) |
| octreotide | 50 µg SC TID titrate to 100-200 µg SC TID | SC | TID | Markham Pediatr Cardiol 2013 + adult case series — somatostatin analog reduces splanchnic blood flow + thoracic-duct lymph flow; alternative to surgery; monitor for hyperglycemia + GI side effects + gallstones with prolonged use |
| lanreotide | 60-120 mg SC monthly | SC | monthly | Long-acting alternative to octreotide for chronic management; once-monthly dosing improves adherence |
| thoracic_duct_ligation_surgical | open thoracotomy or VATS thoracic-duct ligation + pericardial window | surgical | one-time | Riquet EJCTS 1996 + Chen J Cardiothorac Surg 2014 — definitive surgical management; VATS approach minimally invasive; pericardial window prevents recurrence + provides ongoing drainage |
| pericardiectomy | partial or total pericardiectomy | surgical | one-time | Definitive for constrictive sequelae; rarely needed in chylopericardium but reported (Akamatsu PMID 8311605) |
| acetaminophen | 650-1000 mg q6h scheduled | PO | q6h | Preferred analgesic; NSAIDs avoided as inflammatory component minimal in chylopericardium and may not address mechanism |
| normal saline | 500-1000 mL bolus pre-drainage | IV | rapid bolus | Bridge preload (ESC 2015) |
| norepinephrine | 0.05-0.1 µg/kg/min titrate MAP ≥65 | IV | continuous | Bridge only — does not address obstruction (Roy JAMA 2007) |
| lymphoma_directed_chemotherapy | per oncology (e.g., R-CHOP for DLBCL, ABVD for Hodgkin) | IV | per regimen | Lyon EHJ 2022 PMID 35993161 — treating underlying lymphoma resolves chylopericardium when caused by lymphatic compression/infiltration |
| rifampin_isoniazid_pyrazinamide_ethambutol_RIPE | standard 4-drug RIPE × 2 mo intensive then 4 mo continuation | PO | daily | CDC/ATS/IDSA TB treatment guidelines + Cherian Indian J Tuberc 2018 — TB lymphadenitis treatment resolves chylous compression |
| warfarin | 2.5-5 mg PO daily INR target 2-3 | PO | daily | Anticoagulation for upper extremity DVT/SVC syndrome causing thoracic-duct outflow obstruction; balance with bleeding risk in pericardial drainage (CHEST 2021 AC guideline) |
Plan: Chylopericardium — pericardiocentesis bridge + conservative MCT diet → octreotide → surgical thoracic-duct ligation + pericardial window (ESC 2015 §Specific Etiologies; Akamatsu Ann Thorac Surg 1994 PMID 8311605; Markham Pediatr Cardiol 2013; Riquet EJCTS 1996)
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Guideline: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases (Adler EHJ 2015 PMID 26320112) §Specific Etiologies — primary; Akamatsu Ann Thorac Surg 1994 PMID 8311605 anchors classification + management algorithm; Riquet EJCTS 1996 + Chen J Cardiothorac Surg 2014 anchor surgical thoracic-duct ligation; Markham Pediatr Cardiol 2013 anchors octreotide therapy; Kshettry Ann Thorac Surg 1996 anchors post-cardiac-surgery etiology; Imazio JACC 2020 PMID 32919577 + Lyon EHJ 2022 PMID 35993161 anchor neoplastic overlap; Cherian Indian J Tuberc 2018 anchors TB-related chylopericardium; CDC/ATS/IDSA TB guidelines for ATT regimen; Imazio JAMA 2015 PMID 26461998 anchors pericardial disease diagnosis + management overview.